ETF Managers Trust > ETF Managers Trust
ETFMG Treatments Testing and Advancements ETF
$19.84M
Avg Monthly Net Assets
$16.65M
Total Assets
$3.87M
Total Liabilities
$12.78M
Net Assets
ETFMG Treatments Testing and Advancements ETF is an Exchange-Traded Fund in ETF Managers Trust
from ETF Managers Trust,
based in New Jersey,
United States of America.
The fund has one share class
and monthly net assets of $19.84M.
On February 28th, 2024 it reported 64 holdings, the largest
being Mount Vernon Liquid Assets Portfolio, LLC (29.9%), Moderna Inc (6.8%) and Alnylam Pharmaceuticals Inc (6.1%).
Data provided by Fincoded.
Share Classes
| Name | Class/Contract ID | Exchange | Ticker | Monthly Returns (2 years) |
|---|---|---|---|---|
| ETFMG Treatments, Testing and Advancements ETF | C000220417 | ARCX | GERM |
Holdings
From latest NPORT-P, filed February 28th, 2024 for period ending December 31st, 2023.
Historic holdings data available from Fincoded.
| Name | Profile | Category | Country | Value $USD | # Shares | % of Fund |
|---|---|---|---|---|---|---|
| Abbott Laboratories | Long | Equity-common | US | $92K | 838 | 0.72 |
| AbbVie Inc | Long | Equity-common | US | $95K | 614 | 0.74 |
| AbCellera Biologics Inc | Long | Equity-common | CA | $420K | 74K | 3.29 |
| Adaptive Biotechnologies Corp | Long | Equity-common | US | $180K | 37K | 1.41 |
| Alnylam Pharmaceuticals Inc | Long | Equity-common | US | $776K | 4K | 6.07 |
| Altimmune Inc | Long | Equity-common | US | $153K | 14K | 1.20 |
| AN2 Therapeutics Inc | Long | Equity-common | US | $155K | 8K | 1.21 |
| Arbutus Biopharma Corp | Long | Equity-common | US | $106K | 43K | 0.83 |
| Arcturus Therapeutics Holdings Inc | Long | Equity-common | US | $214K | 7K | 1.67 |
| AstraZeneca PLC | Long | Equity-common | GB | $91K | 1K | 0.71 |
| Atea Pharmaceuticals Inc | Long | Equity-common | US | $65K | 21K | 0.50 |
| Bio-Rad Laboratories Inc | Long | Equity-common | US | $481K | 1K | 3.76 |
| BioCryst Pharmaceuticals Inc | Long | Equity-common | US | $311K | 52K | 2.43 |
| BioNTech SE | Long | Equity-common | DE | $717K | 7K | 5.61 |
| CEL-SCI Corp | Long | Equity-common | US | $34K | 13K | 0.27 |
| Chimerix Inc | Long | Equity-common | US | $22K | 23K | 0.17 |
| CorMedix Inc | Long | Equity-common | US | $52K | 14K | 0.41 |
| Cue Biopharma Inc | Long | Equity-common | US | $30K | 11K | 0.24 |
| Cue Health Inc | Long | Equity-common | US | $6K | 39K | 0.05 |
| CureVac NV | Long | Equity-common | DE | $239K | 57K | 1.87 |
| Dynavax Technologies Corp | Long | Equity-common | US | $458K | 33K | 3.58 |
| Eli Lilly & Co | Long | Equity-common | US | $86K | 148 | 0.67 |
| Emergent BioSolutions Inc | Long | Equity-common | US | $32K | 13K | 0.25 |
| Enanta Pharmaceuticals Inc | Long | Equity-common | US | $50K | 5K | 0.39 |
| Enzo Biochem Inc | Long | Equity-common | US | $18K | 13K | 0.14 |
| ETFMG Sit Ultra Short ETF | Long | Equity-common | US | $0 | 0 | – |
| First American Government Obligations Fund | Long | Short-term investment vehicle | US | $95K | 95K | 0.74 |
| Fulgent Genetics Inc | Long | Equity-common | US | $217K | 8K | 1.70 |
| Gilead Sciences Inc | Long | Equity-common | US | $92K | 1K | 0.72 |
| Gritstone bio Inc | Long | Equity-common | US | $49K | 24K | 0.39 |
| GSK PLC | Long | Equity-common | GB | $90K | 2K | 0.70 |
| Gurnet Point Capital LLC | Long | Equity-common | US | $1K | 17K | 0.01 |
| HilleVax Inc | Long | Equity-common | US | $197K | 12K | 1.54 |
| Hologic Inc | Long | Equity-common | US | $88K | 1K | 0.69 |
| Icosavax Inc | Long | Equity-common | US | $200K | 13K | 1.57 |
| ImmunityBio Inc | Long | Equity-common | US | $620K | 123K | 4.85 |
| Immunocore Holdings PLC | Long | Equity-common | GB | $589K | 9K | 4.61 |
| InflaRx NV | Long | Equity-common | DE | $24K | 15K | 0.19 |
| Inovio Pharmaceuticals Inc | Long | Equity-common | US | $35K | 69K | 0.28 |
| Invivyd Inc | Long | Equity-common | US | $110K | 28K | 0.86 |
| Johnson & Johnson | Long | Equity-common | US | $89K | 565 | 0.69 |
| Laboratory Corp of America Holdings | Long | Equity-common | US | $714K | 3K | 5.59 |
| Merck & Co Inc | Long | Equity-common | US | $93K | 853 | 0.73 |
| Moderna Inc | Long | Equity-common | US | $872K | 9K | 6.83 |
| Mount Vernon Liquid Assets Portfolio, LLC | Long | Short-term investment vehicle | US | $4M | 4M | 29.95 |
| Novavax Inc | Long | Equity-common | US | $145K | 30K | 1.13 |
| Ocugen Inc | Long | Equity-common | US | $37K | 65K | 0.29 |
| OPKO Health Inc | Long | Equity-common | US | $296K | 196K | 2.32 |
| OraSure Technologies Inc | Long | Equity-common | US | $153K | 19K | 1.20 |
| Pfizer Inc | Long | Equity-common | US | $83K | 3K | 0.65 |
| Quest Diagnostics Inc | Long | Equity-common | US | $685K | 5K | 5.36 |
| QuidelOrtho Corp | Long | Equity-common | US | $487K | 7K | 3.81 |
| Regeneron Pharmaceuticals Inc | Long | Equity-common | US | $93K | 106 | 0.73 |
| Renovaro Biosciences Inc | Long | Equity-common | US | $54K | 17K | 0.42 |
| Sanofi SA | Long | Equity-common | FR | $93K | 2K | 0.73 |
| Scilex Holding Co | Long | Equity-common | US | $1.18 | 0.58 | 0.00 |
| SIGA Technologies Inc | Long | Equity-common | US | $101K | 18K | 0.79 |
| Takeda Pharmaceutical Co Ltd | Long | Equity-common | JP | $88K | 6K | 0.69 |
| Vaxart Inc | Long | Equity-common | US | $22K | 39K | 0.17 |
| Vaxcyte Inc | Long | Equity-common | US | $551K | 9K | 4.31 |
| Vaxxinity Inc | Long | Equity-common | US | $27K | 32K | 0.21 |
| Vir Biotechnology Inc | Long | Equity-common | US | $343K | 34K | 2.68 |
| XBiotech Inc | Long | Equity-common | US | $31K | 8K | 0.24 |
| Zai Lab Ltd | Long | Equity-common | CN | $455K | 17K | 3.56 |
Address
ETF Managers Trust
350 Springfield Ave
Suite 200
Summit
New Jersey
07901
United States of America
Websites
Directors
Eric Weigel
Terry Loebs
Transfer Agents
U.S. Bancorp Fund Services LLC
Pricing Services
Intercontinental Exchange Inc.
Custodians
U.S. Bank National Association
Shareholder Servicing Agents
N/A
Admins
U.S. Bancorp Fund Services LLC
Brokers
Baypoint Trading LLC/Bass Trading, Bass Trading, BTIG LLC
Mizuho Securities USA, Miziho Securities USA Inc, BNY/Mizuho Securities USA Inc., Mizuho Trust & Banking Co.
Merrill Lynch Inc, BAML, Banc of America Capital Management Inc., Bank of America, Bank of America N.A.
Virtu Americas, LLC